What You Should Know:
- The FDA has listed Mira's new Mira Ovum Wand as an over-the-counter tool to detect the follicle-stimulating hormone (FSH) in urine. Starting October 2022, the product will be available to U.S. customers. The wands help monitor FSH levels to predict approaching menopause. They can also be used to monitor fertility and find possible causes of reproductive issues for women after 35.
- Mira's new Ovum Wand provides lab-accurate detection of the follicle-stimulating
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
TidalHealth to Deploy AI Co-Pilot to Combat Clinician Burnout
What You Should Know:
- TidalHealth, a health system dedicated to community health and patient-centric care, today announced a new partnership with Regard, a company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, and hip.
- Through the implementation of Regard’s software, physicians within the TidalHealth network are able to automate electronic health record (EHR) chart reviews and enhance patient safety by ensuring all diagnoses are
Read More
Digital Pharmacies 2022: Disruptors or Just Another Delivery Channel?
New Insider Intelligence report highlights the current state of digital pharmacies in 2022 along with the challenges and digital opportunities for online pharmacies to appeal to consumers.
With cost and convenience at the forefront of consumer spending decisions and US prescription drug spending continuing to rise through 2026 to an estimated $730.50 billion, winners will offer consumers more robust online resources including pricing transparency, discounts, generic options and more
Read More
Brave Health & MedArrive Partner to Power Virtual Mental Health
- Brave Health, a virtual-first behavioral health provider focused on serving Medicaid and Medicare populations, today announced an innovative referral partnership with MedArrive.
- Through this collaboration, if MedArrive identifies an eligible health plan member in need of mental health support, MedArrive’s field providers can immediately refer that member to Brave Health’s behavioral health providers in real time and schedule care within 72 hours. Conversely, if Brave Health identifies an
Read More
Doceree Partners with Tealium to Enrich Precision Targeting of HCPs
What You Should Know:
- Doceree, a global platform building unprecedented solutions for HCP programmatic marketing with proprietary data tools is teaming up with Tealium, the world’s largest independent customer data platform (CDP) to advance Doceree’s capabilities to collect, collate and analyze data sets, ultimately helping with the company's mission of reducing healthcare costs.
- US healthcare costs grew by 9.7 percent in 2020 alone, highlighting the need for healthcare providers
Read More
How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement
Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need
Read More
Can We Reach Health 4.0 in the Next 3-5 Years?
What You Should Know:
- According to a new report from Allison + Partners, 57% of respondents said it will be possible to achieve “Health 4.0” in the next 3-5 years
- The report illustrates that the biggest hurdles include legislative and regulatory policy, lack of tech talent, and little understanding of health technologies and that the opportunities outweigh the challenges
Health 4.0: Barriers and Solutions
During the pandemic, there was a record-breaking infusion of capital into
Read More
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
AmerisourceBergen Launches EHR-Integrated Digital Therapeutics Platform
What You Should Know:
This week, AmerisourceBergen announced plans to launch DTx Connect, a fully integrated ordering, dispensing and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and diagnostics.
- Several developers plan to pilot DTx Connect, which aims to reduce barriers that physicians and patients face across the ordering and fulfillment of digital therapeutics and diagnostics.
Digital Therapeutics Market
Read More
Elevation Oncology Secures $50M Loan Facility with K2 HealthVentures
What You Should Know:
Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior secured loan facility from funds managed by K2 HealthVentures.
Elevation plans to use the funding from the facility will primarily support the exclusive license of EO-3021 (SYSA1801) outside of Greater China from CSPC Pharmaceutical Group and the
Read More
